buthionine sulfoximine has been researched along with transferrin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hawkins, C; Ponka, P; Richardson, DR; Watts, RN | 1 |
Gong, S; Hu, Y; Lu, M; Luo, Y; Ma, XN; Tian, J; Wu, Y; Xu, Z; Yu, BY; Yu, XA; Zhang, Y | 1 |
2 other study(ies) available for buthionine sulfoximine and transferrin
Article | Year |
---|---|
Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multidrug resistance-associated protein 1.
Topics: Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Cell Line; Cell Proliferation; Enzyme Inhibitors; Glutathione; Humans; Iron; Iron Radioisotopes; Mice; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Spermine; Temperature; Transferrin | 2006 |
A cancer-specific activatable theranostic nanodrug for enhanced therapeutic efficacy via amplification of oxidative stress.
Topics: Animals; Artemisinins; Buthionine Sulfoximine; Drug Carriers; Female; Glutathione; Hep G2 Cells; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Oxidation-Reduction; Oxidative Stress; Precision Medicine; Reactive Oxygen Species; Transferrin | 2020 |